IPA (ImmunoPrecise Antibodies) EBITDA Margin % : -24.89% (As of Oct. 2024)

ImmunoPrecise Antibodies EBITDA Margin % Chart

ImmunoPrecise Antibodies Annual Data
	Trend	Dec14	Dec15	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
EBITDA Margin %		Get a 7-Day Free Trial					-3.20	-7.92	-61.94	-101.79	-93.60

ImmunoPrecise Antibodies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
EBITDA Margin %	Get a 7-Day Free Trial															-20.04	-34.46	-266.87	-64.17	-24.89

Competitive Comparison of ImmunoPrecise Antibodies's EBITDA Margin %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunoPrecise Antibodies's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's EBITDA Margin % falls into.

ImmunoPrecise Antibodies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ImmunoPrecise Antibodies's EBITDA Margin % for the fiscal year that ended in Apr. 2024 is calculated as

ImmunoPrecise Antibodies's EBITDA Margin % for the quarter that ended in Oct. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunoPrecise Antibodies  (NAS:IPA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ImmunoPrecise Antibodies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description